Skip to content

Efficiency of different types of platelet-rich plasma in the repair of rotator cuff injury: a randomized controlled trial

Efficiency of different types of platelet-rich plasma in the repair of rotator cuff injury: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113374
Enrollment
Unknown
Registered
2025-11-27
Start date
2026-02-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Injury (RCI)

Interventions

PRP 1:Inject platelet-rich plasma with no red cells but no white cells
PRP 2:Inject white blood cells, platelet-rich plasma with red blood cells

Sponsors

Department of Rehabilitation Medicine, Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with RCI by magnetic resonance imaging (MRI) with clinical signs after shoulder dysfunction 2.The degree of tears is diagnosed partial-thickness rotator cuff tears (PTRCTs). 3.Patients choose PRP injection therapy.

Exclusion criteria

Exclusion criteria: 1. Previous scapular dysfunction 2. Impairment of shoulder joint movement due to central or peripheral nerve injury 3. Trauma combined with upper limb fracture 4. Other diseases are not suitable for rehabilitation 5. Refusal of platelet-rich plasma injection therapy; Or combined infection should not be injected treatment 6. Patients select surgical repair

Design outcomes

Primary

MeasureTime frame
MRI;CMS;VAS;

Secondary

MeasureTime frame
Ultrasound scanning;SF-12;

Countries

China

Contacts

Public ContactChi Zhang

Department of Rehabilitation Medicine, Affiliated Hospital of Southwest Medical University

chizhang0123@swmu.edu.cn+86 181 2198 7620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 15, 2026